Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis
AustriaStudy on the Safety and Tolerability of VRDN-003 for Patients with Thyroid Eye Disease
FranceStudy Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments
AustriaStudy of sublingual birch pollen extract (SLI-RX-BET) in different doses for patients with moderate to severe allergic rhinitis caused by birch pollen
GermanyStudy on the Long-term Effects of Dupilumab for Patients with Aspirin-Exacerbated Respiratory Disease (AERD)
AustriaStudy on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease
GermanyStudy on the Safety and Effects of Baricitinib in People with HIV
SpainStudy on the Effectiveness and Safety of Tildrakizumab for Patients with Moderate to Severe Genital Psoriasis
BulgariaStudy on the Effects of Remibrutinib for Patients with Generalized Myasthenia Gravis
BelgiumStudy on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment
FranceStudy on the Effects of Ianalumab in Patients with Sjögren's Syndrome
FranceStudy on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma
BulgariaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
